The FDA granted fast track designation to PAS-004, a macrocyclic MEK inhibitor, for NF1-associated plexiform neurofibromas ...
Cocrystal Pharma, Inc. COCP shares are trading higher Thursday after the company announced that it has received Fast Track ...
FDA Fast Track designation supports accelerated development and expedites regulatory reviewNorovirus is responsible for an ...
Fast Track Designation highlights potential of CTIM-76 to address unmet need for patients with PROCCTIM-76 Phase 1a trial ongoing, with interim ...
Context Therapeutics (CNTX) added ~11% on Thursday after the cancer drug developer said that the U.S. Food and Drug Administration (FDA) issued its Fast Track Designation to CTIM-76, the lead asset of ...
A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage immunotherapy company developing first-in-class logic-gated therapies for ...
Shares of Context Therapeutics rose after the Food and Drug Administration moved to expedite its review of the biopharmaceutical company's treatment for ovarian cancer. The stock climbed 8.7% to $2.88 ...
"We are pleased that the FDA has granted Fast Track designation for CDI-988, marking a significant milestone for Cocrystal ...
The FDA has granted Fast Track designation to ZW191, an antibody-drug conjugate (ADC) targeting folate receptor-α (FRα), for ...
Palvella Therapeutics (NasdaqCM:PVLA) reported positive Phase III results for its lead therapy targeting a rare disease with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results